Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 1
2007 1
2009 2
2010 1
2011 1
2013 3
2014 4
2015 1
2016 1
2017 2
2018 2
2019 3
2020 2
2021 6
2022 3
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Temporomandibular joint disorder (review).
Dugashvili G, Menabde G, Janelidze M, Chichua Z, Amiranashvili I. Dugashvili G, et al. Among authors: janelidze m. Georgian Med News. 2013 Feb;(215):17-21. Georgian Med News. 2013. PMID: 23482357 Review.
Eye movements in ephedrone-induced parkinsonism.
Bonnet C, Rusz J, Megrelishvili M, Sieger T, Matoušková O, Okujava M, Brožová H, Nikolai T, Hanuška J, Kapianidze M, Mikeladze N, Botchorishvili N, Khatiashvili I, Janelidze M, Serranová T, Fiala O, Roth J, Bergquist J, Jech R, Rivaud-Péchoux S, Gaymard B, Růžička E. Bonnet C, et al. Among authors: janelidze m. PLoS One. 2014 Aug 12;9(8):e104784. doi: 10.1371/journal.pone.0104784. eCollection 2014. PLoS One. 2014. PMID: 25117825 Free PMC article.
Mild Cognitive Impairment in Republic of Georgia.
Janelidze M, Mikeladze N, Bochorishvili N, Dzagnidze A, Kapianidze M, Mikava N, Khatiashvili I, Mirvelashvili E, Shiukashvili N, Lynch J, Nadareishvili Z. Janelidze M, et al. Gerontol Geriatr Med. 2018 May 4;4:2333721418771408. doi: 10.1177/2333721418771408. eCollection 2018 Jan-Dec. Gerontol Geriatr Med. 2018. PMID: 29761134 Free PMC article.
36 results